As filed with the Securities and Exchange Commission on _________, 2011

                                                     Registration No. 333-173492

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                    FORM S-8
                         Post Effective Amendment No. 1
                             REGISTRATION STATEMENT
                         UnderThe Securities Act of l933

                                DNA BRANDS, INC.

               (Exact name of issuer as specified in its charter)

                   Colorado                          26-0394476
         --------------------------------        --------------------
         (State or other jurisdiction of         (I.R.S. Employer
         incorporation or organization)           Identification No.)

                  506 N.W. 77th Street
                  Boca Raton, Florida                         33487
         ----------------------------------------         -----------
         (Address of Principal Executive Offices)          (Zip Code)

                           Incentive Stock Option Plan
                         Non-Qualified Stock Option Plan
                                Stock Bonus Plan
                         -------------------------------
                              (Full Title of Plan)

                                  Darren Marks
                                506 N.W. 77th St.
                              Boca Raton, FL 33487
                     ---------------------------------------
                     (Name and address of agent for service)

                                 (954) 978-8401
               ---------------------------------------------------
              (Telephone number, including area code, of agent for
                                    service)

  Copies of all communications, including all communications sent to agent for
                                  service to:

                              William T. Hart, Esq.
                                  Hart & Trinen
                             l624 Washington Street
                             Denver, Colorado 80203
                                 (303) 839-0061





7

                         CALCULATION OF REGISTRATION FEE

                                          Proposed      Proposed
Title of                                   maximum       maximum
securities                    Amount       offering     aggregate   Amount of
 to be                        to be         price       offering   registration
registered                 registered (1) per share (2)  price         fee
-------------------------------------------------------------------------------


Common Stock issuable
pursuant to Incentive
Stock Option Plan            500,000        $0.95       $475,000

Common Stock issuable
pursuant to
Non-Qualified Stock
Option Plan                1,000,000        $0.95        950,000

Common Stock issuable
pursuant to Stock
Bonus Plan                   900,000        $0.95        855,000
                                                         -------
                                                      $2,280,000       $265
                                                      ==========

(1)  This Registration Statement also covers such additional number of shares,
     presently undeterminable, as may become issuable in the event of stock
     dividends, stock splits, recapitalizations or other changes in the
     Company's common stock.

(2)  Varied, but not less than the fair market value on the date that the
     options were or are granted. Pursuant to Rule 457(g), the proposed maximum
     offering price per share and proposed maximum aggregate offering price are
     based upon closing price of DNA's common stock on April 4, 2011.






                                DNA BRANDS, INC.
                         Cross Reference Sheet Required
                              Pursuant to Rule 404

                                     PART I
                       INFORMATION REQUIRED IN PROSPECTUS

(NOTE:   Pursuant to instructions to Form S-8, the Prospectus described below is
         not required to be filed with this Registration Statement.)

Item
 No.      Form S-8 Caption                          Caption in Prospectus

  1.     Plan Information

         (a)  General Plan Information              Stock Option and Bonus Plans

         (b)  Securities to be Offered              Stock Option and Bonus Plans

         (c)  Employees who may Participate         Stock Option and Bonus Plans
              in the Plan

         (d)  Purchase of Securities Pursuant       Stock Option and Bonus Plans
              to the Plan and Payment for
              Securities Offered

         (e) Resale Restrictions                    Resale of Shares by
                                                    Affiliates

         (f)  Tax Effects of Plan                   Stock Option and Bonus Plans
              Participation

         (g)  Investment of Funds                   Not Applicable.

         (h)  Withdrawal from the Plan;             Other Information Regarding
              Assignment of Interest                the Plans

         (i)  Forfeitures and Penalties             Other Information Regarding
                                                    the Plans

         (j)  Charges and Deductions and            Other Information Regarding
              Liens Therefore                       the Plans

2.       Registrant Information and Employee        Available Information,
         Plan Annual Information                    Documents Incorporated by
                                                    Reference

                                       3


                  PART IIINFORMATION NOT REQUIRED IN PROSPECTUS
Item 3 - Incorporation of Documents by Reference

     The  following  documents  filed with the  Commission  by DNA Brands,  Inc.
("DNA")  (Commission File No. 000-53086) are incorporated by reference into this
prospectus:

      (1) Annual Report on Form 10-K for the fiscal year ended October 31, 2009.

      (2) Report on Form 10-Q for the three months ended January 31, 2010.

      (3) Report on Form 10-Q for the three months ended April 30, 2010.

      (4) Schedule 14f-1 filed on July 2, 2010.

      (5) Report on Form 8-K filed on July 12, 2010.

      (6) Report on Form 8-K filed July 15, 2010.

      (7) Report on form 10-Q for the three months ended July 31, 2010.

      (8) Report on Form 8-K filed September 13, 2010.

      (9) Report on Form 8-K/A filed September 16, 2010.

      (11) Report on Form 8-K filed on September 16, 2010.

      (12) Report on Form 10-Q for the three months ended September 30, 2010.

      (13) Report on Form 8-K/A filed October 18, 2010.

      (14) Report on Form 8-K filed on November 16, 2010.

      (15) Report on Form 8-K/A filed on December 8, 2010.

      (16) Registration Statement on Form S-1 filed on December 15, 2010.

      (17) Report on Form 8-K/A filed on January 11, 2011.

      (18) Report on Form 10-Q/A filed on January 11, 2011.

      (19) Annual Report on Form 10-K for the fiscal year ended December 31,
2010.


     All documents  filed with the Commission by DNA pursuant to Sections 13(a),
13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this prospectus
and prior to the termination of this offering shall be deemed to be incorporated
by reference into this  prospectus and to be a part of this  prospectus from the
date of the filing of such  documents.  Any  statement  contained  in a document
incorporated  or deemed to be  incorporated  by reference  shall be deemed to be
modified or superseded for the purposes of this  prospectus to the extent that a
statement  contained in this  prospectus or in any  subsequently  filed document
which also is or is deemed to be  incorporated  by reference in this  prospectus
modifies or supersedes such statement.  Such statement so modified or superseded
shall not be deemed,  except as so modified or superseded,  to constitute a part
of this prospectus.

                                       4


     Investors  are  entitled to rely upon  information  in this  prospectus  or
incorporated  by  reference  at the  time it is used by DNA to  offer  and  sell
securities,  even  though  that  information  may be  superseded  or modified by
information subsequently incorporated by reference into this prospectus.

     DNA has filed with the  Securities  and Exchange  Commission a Registration
Statement  under the  Securities  Act of l933,  as amended,  with respect to the
securities  offered by this prospectus.  This prospectus does not contain all of
the information set forth in the Registration Statement. For further information
with respect to DNA and such  securities,  reference is made to the Registration
Statement and to the exhibits filed with the Registration Statement.  Statements
contained  in this  prospectus  as to the  contents  of any  contract  or  other
documents are summaries which are not necessarily complete, and in each instance
reference  is made to the copy of such  contract or other  document  filed as an
exhibit to the  Registration  Statement,  each such statement being qualified in
all respects by such reference.  The Registration Statement and related exhibits
may also be examined at the Commission's internet site.

Item 4 - Description of Securities

     Not required.

Item 5 - Interests of Named Experts and Counsel

     Not Applicable.

Item 6 - Indemnification of Directors and Officers

     The Articles of  Incorporation  of DNA provide in substance  that DNA shall
indemnify  any person who was or is a party or is  threatened to be made a party
to any  threatened  or completed  action,  suit or  proceeding,  whether  civil,
criminal,  administrative,  or  investigative  by  reason  of the fact that such
person is or was a director, officer, employee, fiduciary or agent of DNA, or is
or was serving at the request of DNA as a director, officer, employee, fiduciary
or agent of another  corporation,  partnership,  joint  venture,  trust or other
enterprise,  against expenses (including attorney's fees), judgments,  fines and
amounts paid in settlement  actually and  reasonably  incurred by such person to
the full  extent  permitted  by the  laws of the  state  of  Colorado;  and that
expenses  incurred  in  defending  any such civil or  criminal  action,  suit or
proceeding  may be paid  by DNA in  advance  of the  final  disposition  of such
action,  suit or  proceeding  as  authorized  by the Board of  Directors  in the
specific case upon receipt of an  undertaking  by or on behalf of such director,
officer or employee to repay such  amount to DNA unless it shall  ultimately  be
determined  that such person is entitled to be  indemnified by DNA as authorized
in the Articles of Incorporation.

Item 7 - Exemption for Registration Claimed

     Not Applicable

                                       5



Item 8 - Exhibits

4  - Instruments Defining Rights of
     Security Holders

   (a) - Common Stock                       Incorporated  by reference to
                                            Exhibit 3.1 of the Company's
                                            Registration  Statement on Form
                                            SB-2, File No. 333-148773.

   (b) - Incentive Stock Option Plan        (1)

   (c) - Non-Qualified Stock Option Plan    (1)

   (d) - Stock Bonus Plan                   (1)


5  - Opinion Regarding Legality             (1)

l5 - Letter Regarding Unaudited Interim
     Financial Information                  None

23 - Consent of Independent Public
     Accountants and Attorneys              (1)

24 - Power of Attorney                      Included in the signature page of
                                            this Registration Statement

99 - Re-Offer Prospectus                    __________________________________

(1) Filed with original registration statement

                                       6


POWER OF ATTORNEY

     KNOW ALL MEN BY THESE PRESENTS,  that each of the  undersigned  constitutes
and appoints Darren Marks and Mel Leiner,  and each of them, his true and lawful
attorneys-in-fact   and   agents,   with   full   power  of   substitution   and
resubstitution,  for  him  and in his  name,  place  and  stead,  in any and all
capacities, to sign any and all amendments (including post-effective amendments)
to this Registration Statement, and to file the same, with all exhibits thereto,
and all  other  documents  in  connection  therewith,  with the  Securities  and
Exchange Commission granting unto said  attorneys-in-fact  and agents full power
and  authority  to do and  perform  each and every act and thing  requisite  and
necessary to be done,  as fully to all intents and purposes as he might or could
do in person,  hereby  ratifying and confirming all that said  attorneys-in-fact
and agents or their  substitutes  or  substitute  may lawfully do or cause to be
done by virtue hereof.

                                   SIGNATURES

     Pursuant to the  requirements of the Securities Act of l933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in Boca Raton, Florida, on May 5, 2011.

                                DNA BRANDS, INC.

                                       By: /s/ Darren Marks
                                          --------------------------
                                             Darren Marks, President

     Pursuant  to  the   requirements  of  the  Securities  Act  of  l933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the dates indicated.

Signature                               Title                   Date
---------                               -----                   -----
/s/ Darren Marks                                               May 5, 2011
-------------------------        Principal Executive
Darren Marks                     Officer and a Director


/s/ Melvin Leiner                                              May 5, 2011
-------------------------
Melvin Leiner                    Principal Financial and
                                 Accounting Officer
                                 and a Director

                                       7